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Abstract
Secreted frizzled related proteins (sFRP) are regulators of Wnt signaling pathways that play central roles in developmental processes and
oncogenesis. Various sFRP genes have been cloned from different tissues and implicated in diverse biological activities. rFrp, the rat
homologue of sFRP-4, was initially identified as being upregulated in mutant p53-induced cellular transformation. Here, we report on the
isolation of five novel splice variants, rFrp/sFRP-4 II, II, III, IVa and IVb. The complete rFrp/sFRP-4 genomic structure spans over 31 kb
covering 9 exons. Except for the variant IVb, which was derived from IVa by alternative polyadenylation signal, variants I to IVa were
alternatively spliced to different exons in the 3’end of mRNA and resulted in transcripts with truncated open reading frame. The deduced
proteins of the variants had truncated C-termini, however, the two key functional protein domains, the cysteine-rich domain and the netrin-
like domain of the isoforms, were not altered. In addition, different transcriptional initiation sites were found with variants II and IV, implying
that these variants may be regulated differently from the rFrp/sFRP-4. RT-PCR analysis showed that these splice variants displayed different
patterns of tissue-specific expression. Northern blot analysis revealed that the rFrp/sFRP-4 is most abundant in the ovary. Taken together, our
findings suggest that alternative splicing of rFrp/sFRP-4 plays a role in regulating tissue-specific expression. The truncated C terminals of
rFrp/sFRP-4 variants may confer structural specificity and hence exert different biological functions in different tissues. Characterization of
these novel splice variants should help to elucidate the function of the sFRP family gene.
D 2005 Elsevier B.V. All rights reserved.
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1. Introduction
Secreted frizzled related protein (sFrp) homologues have
been independently isolated from bovine, Xenopus, mouse,
rat and human tissues by different laboratories (Hoang et al.,
1996; Leyns et al., 1997; Wang et al., 1997; Rattner et al.,
1997; Wolf et al., 1997; Zhou et al., 1998; Chang et al.,
1999; Katoh, 2001; Finch et al., 1997). Frp protein contains
a secreted signal peptide at the amino terminus and is
followed by an extracellular cysteine-rich domain (CRD)
which is highly homologous with the CRD present in the
frizzled (Fz) family proteins (Hoang et al., 1996; Leyns et
al., 1997; Rattner et al., 1997). The discovery of the CRD
motif led to the finding that sFrp may act as an antagonist,
competing with Fz for Wnt ligands, thereby modulating
Wnt signals during development and carcinogenesis (Finch
et al., 1997; Bafico et al., 1999; Dennis et al., 1999; Wada et
al., 1999; Ladher et al., 2000; U¨ren et al., 2000; Bergwitz et
al., 2001; Dann et al., 2001; Marvin et al., 2001). The C-
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terminal half of Frp conserves a netrin-like (NTR) domain
that shares weak sequence similarity with the axon guidance
protein, netrin. The NTR domain is also found in other
proteins, including type I procollagen C-proteinase enhancer
proteins, and tissue inhibitors of metalloproteinases. Evi-
dence suggests the NTR domain of Frp may involve matrix
stability, inhibit motility and promote growth of glioma cells
(Roth et al., 2000). The precise interaction of each Frp
protein in modulating Wnt signaling remains to be
elucidated.
The physiological role of Frp is unclear. Involvement of
Frp in apoptosis has been suggested by several investiga-
tors. One early study indicated that a Frp gene, frpAp, acts
as a pro-apoptotic gene in rat corpus luteum (Wolf et al.,
1997). Recently, an apoptotic role of sFrp2 was cited in the
developing CNS (Ellies et al., 2000; Kim et al., 2001).
Another study suggested that FrzB-2/sFrp3 may be involved
in the pathogenesis of human osteoarthritic cartilage through
its role in apoptosis (James et al., 2000; Ijiri et al., 2002). In
human myocardium, expressions of sFRP3 and sFRP4 are
correlated with the expressions of pro-apoptotic genes
(Schumann et al., 2000). The involvement of Frp in human
cancer has also been cited in several recent reports. For
example, down-regulation of Frp expression has been
observed in multiple human tumors, including those in
kidney, breast and ovary, and also in mammary carcinoma
cell lines (Zhou et al., 1998; Ugolini et al., 1999; Ugolini et
al., 2001; Preiherr et al., 2000; Wong et al., 2002). In
contrast, upregulation of FrzB has been found in primary
malignant plasma cells (De Vos et al., 2001). Frp1 has also
been found to promote tumor growth through the anti-
apoptotic effect (Roth et al., 2000; Fukuhara et al., 2002).
The contradictory roles of Frp proteins in apoptosis and
carcinogenesis suggest that different Frps may exert differ-
ent effects in different tissues or organs. Thus, the precise
functional roles of the various Frps remain to be elucidated.
In our previous study, a novel rat Frp (rFrp) gene was
identified as one of the differentially expressed genes
activated in Rat 6 fibroblast cell lines overexpressing
p53val135 tumor suppressor gene. This rFrp gene is normally
silent in the parental Rat 6 (R6) cells (Yam et al., 1999).
Nucleotide sequence alignment indicates that rFrp appears
to be the orthologue of human and mouse sFRP-4 genes and
is referred to as rFrp/sFRP-4 in this study. In the attempt to
understand the molecular basis of the transcriptional
regulation of the rFrp/sFRP-4, a series of studies was
conducted on the promoter region of the gene. We mapped
the regions essential for the transcription of rFrp/sFRP-4,
and this mapping revealed a number of putative consensus
motifs for hematopoietic-specific and sex-determining tran-
scriptional factors (Yam et al., 2001a). In a subsequent
study, we further demonstrated that the cyclic AMP
responsive element binding protein (CREB) transcriptional
factor is crucial for the positive promoter activity of rFrp/
sFRP-4 demonstrated by transient reporter and site direct
mutation assays. More importantly, CREB, phosphorylated
CREB, and the CREB binding protein (CBP) were found
binding to the endogenous rFrp/sFRP-4 promoter in vivo
using chromatin immunoprecipitation assay (Yam et al.,
2003).
As establishing the genomic organization of rFrp/sFRP-
4 and its expression patterns are necessary toward the
understanding of various roles of rFrp/sFRP-4, we report
here on the identification of five novel splice variants of
rFrp/sFRP-4. The genomic origins and tissue specificity of
each splice variant are described in this report. Our findings
provide a framework for elucidating the biological signifi-
cance of the rFrp/sFRP-4 and its isoforms.
2. Materials and methods
2.1. cDNA library screening
A rat brain cDNA library constructed in E Zap II
(Stratagene) was screened using the 32P-labeled 1.7 kb rFrp/
sFRP-4 cDNA (GenBank accession no. AF140346) as
probe. Filters containing 4105 plaques were hybridized
overnight at 42 -C in 50% deionized formamide, 10%
dextran sulphate, 1% SDS and 1 M NaCl solution
containing the 32P-labeled probe. Filters were washed at
65 -C and exposed to autoradiography. One positive clone,
rFrp/sFRP-4IV was isolated by in vivo excision according
to the manufacturer_s protocol.
2.2. 5V- and 3V-rapid amplification of cDNA ends (RACE)
Isolation of rFrp/sFRP-4 cDNA splice variants was
performed using Marathon cDNA Amplification Kit (Clon-
tech) with the T2 adaptor-ligated RACE cDNA library that
we previously constructed (Yam et al., 2001b). The rFrp/
sFRP-4 is highly expressed in T2 cells (Yam et al., 1999).
First round PCR for 5V-and 3V-RACE was performed using
library adaptor-specific primers AP1 (5V-CCATCCTAA-
TACGACTCACTATAGGGC-3V) or AP1A (5V-TAATAC-
GACTCACTATAGGGCTCGA-3V) and rFrp/sFRP-4IV
gene-specific primers E5F (5V-GGATGATGCTTCTT-
GAAAATTGTTTAG-3V) or E9R (5V-GCCACAGCAGTG-
CATACTGCCA-3V). The second round PCR was done using
AP2 (5V-ACTCACTATAGGGCTCGAGCGGC-3V, nested to
AP1 or AP1A) and gene-specific primers nested to primers
E5F and E9R. The 5V-and 3V-RACE products were directly
sequenced by BigDye Terminator Kit using ABI PRISM
377 Automatic Sequencer (Applied Biosystems).
2.3. Determination of genomic structure
Genomic DNA was extracted from the tail of SD rat by
proteinase K digestion. Sense and antisense primers were
designed from each exon of the isolated rFrp/sFRP-4
cDNAs. Amplification of introns using primer pairs
corresponding to the consecutive exons was performed by
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using Expand 20 kb plus PCR system (Roche). PCR
products were then sequenced directly. Determination of
the exon/intron and intron/exon junctions were performed
by sequence alignment between the amplified genomic
DNA clones and the cDNA splice variants by Mac DNASIS
v2 (Hitachi).
2.4. Determination of transcriptional start sites
Transcription initiation sites for splice variants were
mapped using a RACE-based method in conjunction with
the GeneScan Analysis using ABI PRISM 377 Automatic
Sequencer (Applied Biosystems) (Yam et al., 2001b).
Antisense gene-specifc primers E5/E8R and E5/E9R were
designed according to the specific exon/exon junction of
rFrp/sFRP-4II and rFrp/sFRP-4IV cDNA, respectively. The
5V untranslated regions containing the transcriptional start
sites were amplified using AP1 and gene-specific primers.
Nested PCR was then performed using nested fluorescent
labeled library adaptor primer 6-FAM AP2 and nested gene-
specific primers E1R (5V-GCTACCAGGATGGAGAG-
GAGCAT-3V). The nested PCR product was mixed with
GeneScan 400HD [ROX] size standard (Applied Biosys-
tems), denatured and electrophoresed on a 5% polyacryla-
mide gel at constant 3000 V at 51 -C for 2.5 h using ABI
PRISM 377 Automatic Sequencer. Sizes of the PCR
products were determined by GeneScan Analysis, version
3.1 software (Applied Biosystems). Single or multiple
transcription initiation sites of each RACE cDNA were
identified.
2.5. Tissue expression of rFrp/sFRP-4 by RT-PCR
Total RNA was isolated from rat tissues (brain, heart,
thymus, lung, liver, spleen, kidney, adrenal gland, stomach,
intestine, colon, uterus, ovary, testis, skeletal muscle and
skin) of adult SD rat and cell lines (R6#13-8 and T2) (Yam
et al., 1999). First-strand cDNA was synthesized from 5 Ag
of total RNA using SuperScriptTMII RNase H-Reverse
Transcriptase (Gibco BRL) and random hexamer N6 (Gibco
BRL) according to the instructions manual. Each splice
variant was specifically amplified by the respective exon/
exon specific primers using AmpliTaq Gold (Applied
Biosystems) under the following conditions: 95 -C for 12
min and then 50 cycles of 94 -C for 30 s, 64 -C for 1 min,
72 -C for 30 s with a final extension of 5 min.
2.6. Northern blot analysis
Total RNA isolated from rat tissues and poly(A)+RNA
isolated from R6#13-8 and T2 cells were fractionated on a
1% formaldehyde agarose gel and transferred to a Hybond
N-plus membrane (Amersham). The membranes were
hybridized overnight at 42 -C in 50% deionized formamide,
10% dextran sulphate, 1% SDS and 1 M NaCl solution
containing the 32P-labeled rFrp/sFRP-4 cDNA probes.
Filters were washed once in 2SSC and 0.1% SDS, and
once in 1SSC and 0.1% SDS at 65 -C. Membranes were
stripped and reprobed with actin to normalize RNA loading.
2.7. In situ hybridization
Rat ovaries and were fixed overnight in 4% paraformal-
dehyde at 4 -C, embedded in paraffin, subsequently
sectioned and mounted on glass slides. The Sense and
antisense rFrp/sFRP-4 containing plasmids were linearized
with EcoRI and BamHI, respectively. The [35S]-uridine
triphosphate (UTP)-labeled sense and antisense transcripts
were generated using T7 and T3 RNA polymerase,
respectively (Promega). Slides were dewaxed, rehydrated,
and hybridized overnight in a humid box (containing 50%
formamide, 5SSC) with a sense or antisense 35S-labelled
probe in hybridization solution (50% deionized formamide,
0.3 M NaCl, 5 mM EDTA, 20 mM Tris–HCl, 10% dextran
sulphate, 2Denhardt’s buffer, 0.5 mg/ml yeast tRNA, 10
mM DTT) at 55 -C. Following a series of washings under
stringent conditions, the slides were dehydrated and
subsequently dipped into a photographic emulsion (Amer-
sham). The slides covered with emulsion were dried and
stored in the dark at 4 -C. After 3 days of exposure, the
sections were developed.
3. Results and discussion
3.1. Isolation of splice variants of rFrp/sFRP-4
Previously, the rFrp/sFRP-4 cDNA (GenBank accession
no. AF140346) of 1715-bp had been isolated by 5VRACE
from Rat 6 embryo fibroblast cell line transformed by
mutant p53 (T2 cell line) (Yam et al., 1999). With Northern
blot analysis of T2 mRNA, three sizes of transcript: 1.8 kb,
2.1 kb, and 3.3 kb in T2 cells have been identified (Yam et
al., 1999). In order to identify the nucleotide sequence of
each transcript, we screened an adaptor-ligated T2 cDNA
library (T2 Library) that we had constructed earlier (Yam et
al., 2001b). By PCR amplification of the T2 cDNA Library
using various regions of 5V and 3V sequences of rFrp/sFRP-4
cDNA, we identified four rFrp/sFRP-4 splice variants,
which are named as rFrp/sFRP-4I, II, III, and IVa. An
additional splice variant, designated as rFrp/sFRP-4IVb,
was isolated by screening a rat brain cDNA library using the
full-length rFrp/sFRP-4 cDNA as probe (Fig. 1A). rFrp/
sFRP-4IVa and rFrp/sFRP-4IVb are identical except that
rFrp/sFRP-4IVb possesses an extended sequence at the 3V
end, and both transcripts contain a putative poly(A) signal at
the 3V end. These two transcripts are suspected to be
generated by alternated poly(A) sites. Sequence analysis of
the cDNA of all splice variants suggested that these
transcripts share similar sequences at the 5V region, but
differ at the 3V region of the transcripts (Fig. 1A). With the
exception of variant IVb, which contains two adjacent non-
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canonical poly(A) signals, UAUAAA, all variant transcripts
contain the consensus AAUAAA poly(A) sequence at the 3V
terminal. To our knowledge, no other variant of Frp family
genes has ever been reported.
3.2. Genomic organization of rFrp/sFRP-4
In a previous study, a genomic fragment, LS of 4483-
bp (GenBank accession no. AF140347) spanning the
5Vuntranslated region and exons 1 to 3 of rFrp/sFRP-4,
was isolated by genomic library screening using 1.7-kb
rFrp/sFRP-4 cDNA as a probe (Yam et al., 2001a) (Fig. 1B).
To map the remaining genomic structure, we designed
primers based on exon sequences for amplifying genomic
sequences in order to deduce the sizes of exons and introns.
A total of 6 genomic fragments, P1 to P6 with sizes ranging
from 0.5 kb to 9 kb were amplified (Fig. 1B). The exon–
intron boundaries were determined by direct sequencing.
The sequences of the splice junctions are summarized in
Table 1. All of the intron–exon boundaries contained the
consensus splice donor–acceptor pair (GT-AG) except the
Table 1
Sequences of splice junctions of the rFrp/sFRP-4 genew
Exon no. Exon size 5V splice donor 3V splice acceptor Intron size
1 692 bp CGGAAGgtaaga tttcagATGTGA 1.2 kb
2 81 bp GCCCTGgtgagt tttcagATCGGT 0.1 kb
3 66 bp GCTATGgtaagt ttgcagTTATTC 0.8 kb
4 199 bp TTCAAGgtaggt ttttagGATGAT 1.6 kb
5 63 bp TCCACAgtaagt ccccagCAGTGG 2.5 kb
6 615 bp CATGTGtttgtt tggaggGAGACC 8.9 kb
7 72 bp AAACAGgtaaca tttcagGTTCTC 5.1 kb
8 349 bp AACACTactttt tttcagGATGTC 8.6 kb
9a 401 bp – – –
9b 1379 bp – – –
Exon and intron sequences are indicated by uppercase and lowercase letters,
respectively. The consensus splice donor-acceptor sequences are bold.
5 kb
B
    7              8                   9a
P1
P3
P2
P4 P5 P6LS
A
C
rFrp
rFrpI
rFrpII
rFrpIII
rFrpIV-a
1 3 42 5
348 aa
288 aa
305 aa
288 aa
303 aa
rFrp
rFrpI
rFrpII
rFrpIII
rFrpIV
CRD NTD
H
AAAAn
AAAAn
AAAAn
AAAAn
AAAAn
rFrp
rFrpI
rFrpII
rFrpIII
rFrpIVa
rFrpIVb
rFrpIV-b
AAAAn
9b 
1 3 42 5 6
Fig. 1. Schematic representation of the rFrp/sFRP-4 gene and its splice variants. (A) cDNA of splice variants of rFrp/sFRP-4 showing the conserved 5V-end and
the variable 3V-end regions. (B) Genomic organization of rFrp/sFRP-4 gene. The 5V region of rFrp/sFRP-4, clone LS of 4.5-kb was obtained by genomic library
screening using the 1.7-kb rFRP cDNA (GenBank accession no. AF140346) as a probe. Overlapping genomic fragments, P1-P6 were obtained by PCR using
exon/intron-specific primers. Exons are numbered and indicated by boxes. Introns are represented by horizontal lines. Pattern of alternative spicing of each
splice variants are shown below. (C) Schematic representation of the predicted protein structural domains of rFrp/sFRP-4 and its splice variants. The cysteine
rich domain (CRD) is located at residues 22-137 and the netrin-like domain (NTR) resides at residues 187–284, followed by a hydrophobic tail (H). Number
represents the number of residues encoded by the each splice variant.
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5V splice donor of exons 6 (-TT), 8 (-AC) and the 3V splice
acceptors of exon 7 (-GG). Intriguingly, the use of splice site
in creating the variants, in this instance, seems to be
conformed to the canonical GT-AG site, but not to the non-
canonical sequences as found in the human genome (Chong
et al., 2004). This is evidenced by the alternative splicing
activities in generating the isoforms that we observed, i.e.
the 5V splice donor of exon 5 spliced to three 3V splice
acceptors of exon 7, 8, or 9; and 5V splice donor of exon 7,
but not 8, spliced to 3V splice acceptor of exon 8 (Table 1).
Sequence comparison of the isolated genomic fragments
with the known cDNA sequences revealed the full rFrp/
sFRP-4 genomic structure that spans over 31 kb covering at
least 9 exons (Fig. 1B). Until this work, no genomic
structure of Frp genes had been constructed based on the
actual sequencing data. However, the inton–exon relation-
ship of human sFRP4 was deduced based on the available
Ensembl data by Jones and Jomary (2002). Interestingly, the
genomic organization of the predicted sFRP4, which spans
about 11 kb covering exons 1–6 of sFRP4 gene, closely
resembles that of the rFrp/sFRP-4, which was deduced
based on our actual sequence data. In the same report, the
authors also predicted a second transcript variant lacking the
81-bp exon 2. However, we did not detect such a transcript
variant among the rFrp/sFRP-4 splice variant forms.
3.3. Truncated C terminus of rFrp/sFRP-4 splice variants
Except for the rFrp/sFRP-4IVb transcript which was
generated through alternative polyadenylation signal, all
four alternatively spliced transcripts, rFrp/sFRP-4I, II, III
and IVa were produced by perfect exon-skipping and
resulted in in-frame, but truncated open reading frame
(ORF) (Fig. 1C). The translational stop codon of rFrp/
sFRP-4 exists in exon 6 and the ORF of rFrp/sFRP-4
encodes a full-length protein of 348 amino acids.
Structurally, rFrp/sFRP-4 contains a signal peptide
sequence comprising 20–30 amino acids for secretion at
the amino terminus followed by a CRD at amino acid
residues 22–137. A NTR domain is located at residues
187–284 (Banyai and Patthy, 1999) followed by a 60-
amino acid hydrophilic carboxyl terminus. The CRD is
responsible for binding to Wnt protein, and cysteine
disulphide bonds are reported to form within the NTR
domain of sFRP1 (Chong et al., 2002). Both rFrp/sFRP-4I
and rFrp/sFRP-4III transcripts skipped exon 6 and spliced
to exon 7 where translation terminated, and formed the
identical truncated protein with 288 amino acids. Trans-
lation of rFrp/sFRP-4II terminates in exon 8 and has 305
amino acids, while translations of rFrp/sFRP-4IVa and b
presumably terminates in exon 9 and yields same protein
A
rFrpII
rFrpIV
C -393 TTAAAGGGCAACAACAGGGTCGTATTGCTCTAACTCTGTACTTAGAGAAACTTTAGGCTGACTTAGCAAAGAGATTCCTC
-313 AAAGTCTCCCCTGCACCGGCTTATATGCAGCGTCCCAAATGACTGAAAGCAAGGCGCTCCTTTTCTTGATCTGAAGAAAA
-233 AAGACTAGCAGACTGAGGGGGAAAAAAAAAGAGGGACTTTGGGGGAAAT CAGAACTATAGCCCTTGGCTGTGGAGTGGC
-153 GGAGATGATGTAATCGCTTCTGCAGGAGAGGCTGGGGGTGGAGCAGCGGAGCAGGAGCCGGCTCTGCTTTCGCCTCTGCC
-73 AAGGCTGCTGAGCCCACGTCAGGGGACGCGTCTGGATAAATAGGGTCCCACAATGGCCGTGGCCCGCTGCGCTCCGAGCT
+8 GCGGGGCGGGAGACTGGAGCTTCCTGCGCGGGTCTGTGCTCTGGTGGGTGAGTGCTGTCCCTGCCAGTGTCCGGGCGCCC
+88 AGGGCTGATCGACGGCCAGAACCCCAGAACTCCCGTTCAGTGCGGACTGGAGCTCCAGCAGAAACGCTCACTTCGCTGCC
+168 CCTAGGTAAAGACATAAGGAGATCAGAGGGACTTGAAGGGAAGGTCCCCAGTGGGGACCGCAGCCCAGGAGGACAGTGCG
+248 ATGCTCCTCTCCATCCTGGTAGCGTTATGCCTGTGGCTGCGCCTGGCTCTGGGAGTGCGCGGAGCGCCCTGCGAGGCTGT
M  L  L  S  I  L  V  A  L  C  L  W  L  R  L  A  L  G  V  R G  A  P  C  E  A  V 
rFrpIV
rFrpII
B
rFrpII
120 150 160
128
rFrpIV
421 470 490
429
1 2 3 4 5 8
E5/E8RE1RAP1AP2
E5/E9RE1RAP1AP2
1 2 3 4 5 9
rFrp
Fig. 2. Determination of transcriptional start sites of various splice variants. (A) Scheme of the RACE-based GeneScan\ technique. Amplification of the
adaptor-ligated cDNAwas done using AP1 and exon/exon specific primers of each splice variant in the first PCR. The nested PCR was performed with 6-FAM
AP2 and specific primer (close to the start codon) for each splice variant using the first PCR products as template. Primers used in the first PCR and nested PCR
are indicated by filled and open arrowheads, respectively. (B) Electropherogram of nested PCR product of various splice variants analyzed by GeneScan\
software. Locations of peak (upper panel) are aligned with the GeneScan\ 400HD [ROX] size standard (lower panel). Number of transcriptional start sites is
indicated by the number of peaks. (C) Locations of the determined transcriptional start sites of rFrp/sFRP-4. The major transcriptional start site (previously
determined) of rFrp/sFRP-4 is designated as +1 and marked by an arrow ( ). The determined start sites of rFrp/sFRP-4II and rFrp/sFRP-4IV are marked by
arrows (,). The positive cis-acting elements for the transcriptional regulation of rFrp/sFRP-4 are underlined (Yam et al., 2003).
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with 303 amino acids. All splice variants have a
shortened hydrophilic carboxyl tail compared with rFrp/
sFRP-4, but preserve the CRD and NTR domains, thus
revealing the functional significance of these two
domains.
3.4. Determination of transcriptional start sites of rFrp/
sFRP-4 splice variants
To determine the transcription initiation sites of different
splice variants, we employed a RACE-based technique in
conjunction with the GeneScan\ Analysis (Yam et al.,
2001b). As described in Fig. 2A, the 5V flanking region of
each rFrp/sFRP-4 splice variant was amplified by first PCR
using exon/exon specific primers (E5/E8R, E5/E9R) and an
adaptor primer (AP1), followed by a second PCR with a
fluorescence-labeled adaptor primer (6-FAM AP2) and a
nested sequence specific primer (E1R). The size and number
of the labeled PCR products was determined by using
GeneScan\ analysis. The sizes of the PCR products
corresponding to the location of the transcriptional initiation
site upstream from the nested gene specific primer are
indicated as peaks precisely aligned with an internal
fluorescent GeneScan 400HD [ROX] size ladder, while
the number of peaks reflects the number of initiation sites.
As shown in Fig. 2B, distinct PCR products were obtained
for splice variants II and IV, and these PCR products suggest
that each of these two transcripts is transcribed from a single
transcriptional initiation site. The locations of transcriptional
start site of variants II and IV relative to the previously
determined transcriptional start site of rFrp/sFRP-4 (Yam et
al., 2001b) are shown along the promoter region of rFrp/
sFRP-4 (Fig. 2C). Two crucial transcriptional cis-acting
elements of the rFrp/sFRP-4 promoter, CTTTGGGGG and
AGATGATGAA are located in regions of 197 to 189
and 151 to 141, respectively (Yam et al., 2003). The
transcriptional start sites of rFrp/sFRP-4II and rFrp/sFRP-
4IV are located downstream and upstream to these positive
elements, respectively. This finding suggests that rFrp/
sFRP-4 and its splice variants are differentially regulated
by the alternative usage of the promoter regulatory
elements. The utilization of alternative promoters is a
common scheme involved in regulating expression of gene
in a tissue-specific manner. Examples can be found with
genes encoded proteins such as neuronal nitric-oxide
synthase (Newton et al., 2003), P450 aromatase (Payne
and Hales, 2004 and connexins (Anderson et al., 2005). Of
interest to our study, the expression of P450 aromatase,
product of CYP19 gene is found in the corpus luteum of the
rat ovary as what we found with the rFrp/sFRP-4 gene
described below.
We were unable to determine the transcriptional start
sites of variants I and III, due to the extremely low copy
number of the variant transcripts present in the adaptor-
ligated T2 cDNA library that was employed for the RACE
reactions.
3.5. Tissue-specific expression of rFrp/sFRP-4 splice
variants
In view of the complex splicing pattern of rFrp/sFRP-4
transcripts, RT-PCR analysis was done to examine rFrp/
sFRP-4 expression in a panel of rat tissues using exon/exon
specific primer pairs of each splice variant. Two cell lines,
R6#13-8 and T2, from which rFrp/sFRP-4 was first
identified by our lab, were also included as positive controls
in the expression study. The RT-PCR analysis shows that
rFrp/sFRP-4 was ubiquitously expressed in all tissues
examined (Fig. 3). The four splice variants, rFrp/sFRP-4I
to IV, displayed different patterns of tissue distribution.
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Fig. 3. Tissue expression of rFrp/sFRP-4 splice variants. (A) RT-PCR
analysis of alternatively spliced rFrp/sFRP-4 transcripts in various rat tissues.
Total RNA isolated from rat tissues of an adult Sprague-Dawley rat and cell
lines (R6#13-8 and T2) were reverse transcribed and amplified by exon/exon
specific primer pairs for each splice variant. Quality of the isolated RNAwas
revealed by amplification with actin primers. Primer pairs for each splice
variant are shown as follows: rFrp/sFRP-4 (E3F, AGGTGAAGC-
CAACTTTGGCAACGT; E5/E6R,GCCACCTGATGGACATCTGTGGA),
rFrp/sFRP-4I (E3F, E7/E8R, CTGACACTGAGTCGAGAACCTGT), rFrp/
sFRP-4II (E3F, E5/E8R, GACACTGAGTCGAGAACTGTGGA), rFrp/
sFRP-4III (E3F, E7/E9R, TGCCACCTGATGGACATCCTGTT), rFrp/
sFRP-4IV (E3F, E5/E9R, GCCTCTCTTCCCACTGTGTGGA). (B) Total
RNA extracted from various tissues of an 8-week-old female rat was probed
with 32P-radiolabeled rFrp probe. Ethidium bromide staining of total RNA
was used for quantifying RNA on the gel.
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Brain and ovary are the only two tissues that express all five
rFrp/sFRP-4 splice variants. Besides brain and ovary, rFrp/
sFRP-4I and rFrp/sFRP-4III are expressed in uterus and
lung, respectively. The rFrp/sFRP-4II is also expressed in
heart, adrenal gland, stomach and muscles, while rFrp/
sFRP-4IV is expressed in uterus and muscle. Although all
splice variants were detected in different tissues by RT-PCR,
transcripts of rFrp/sFRP-4 were only detected in ovary by
Northern blot analysis using a fulllength rFrp/sFRP-4
cDNA as probe (Fig. 3B). Expressions of rFrp/sFrp-4
poly(A)+RNA in tissues other than ovary were not detected
using Northern blot analysis, suggesting that the copy
number of rFrp/sFrp-4 mRNA are extremely low in non-
ovarian tissues. The sizes of the ovarian transcripts (3.3, 2.1
and 1.8 kb) are identical to the sizes of transcripts found in
mutant p53-transformed R6#13-8 and T2 cells (Yam et al.,
1999). Based on the sequence analyses of the variants, the
transcript sizes of rFrp/sFRP-4, variants I, II, III, IVa and
IVb are 2062, 1765, 1518, 1818, 2063 and 3441bp,
respectively, with the assumption that variants I and III
contain the same transcriptional start site as the rFrp/sFRP-
4. The 3.3 kb band on the Northern blot might be the variant
IVb mRNA, the 2.1 kb band might represent transcripts of
rFrp/sFRP-4 and rFrp/sFRP-4IVa, while the 1.8 kb band
might represent transcripts of rFrp/sFRP-4 I, II, and III.
Another sFRP-4 homologue, DDC-4 (Wolf et al., 1997) was
also found to be expressed in ovary with three discrete
transcripts ranging from 2.9 to 2.0 kb. Most likely, these
transcripts were the products of alternative splicing present
in the rat mammary gland of their study.
To verify the expression of rFrp/sFRP-4 in ovary, in situ
hybridization with rFrp/sFRP-4 specific antisense riboprobe
was performed. As shown in Fig. 4, rFrp/sFRP-4 was
predominantly expressed in luteal cells of corpus luteum.
Only a weak hybridization signal is detected in follicles and
stroma. This result is consistent with the upregulated sFRP4
found in the ovarian corpus luteum around the time of
ovulation (Drake et al., 2003). During the ovulation cycle,
corpus luteum undergoes profound morphological and
functional changes. It is conceivable that the rFrp/sFRP-4
gene and its splice variants may be those of the luteal cell-
specific genes underlying these molecular and structural
changes.
To summarize, in this report, we presented the results of
our work on isolating and characterizing five novel rFrp/
sFRP-4 splice variants that were generated by exon-
skipping at the 3V region of the mRNA. Tissue distribution
of these splice variants suggests that these splice variants
together with rFrp/sFRP-4 might have specific and over-
lapping functions in different tissues. This study provides a
foundation toward the understanding of the tissue-specific
regulation and functional significance of the gene.
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